| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.003 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |